You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • Phase I study of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with pretreated biliary tract cancer

Article metrics

Article menu

Download PDFPDF

XML
Clinical/translational cancer immunotherapy
Original research
Phase I study of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with pretreated biliary tract cancer

 

Online download statistics by month:

Online download statistics by month: May 2020 to March 2024

AbstractFullPdf
May 202019319390
Jun 2020398398159
Jul 202019419460
Aug 202023923763
Sep 202019619697
Oct 2020186186101
Nov 2020939238
Dec 202020720775
Jan 202120220367
Feb 202115015039
Mar 202121421474
Apr 2021999944
May 202110010035
Jun 202112612639
Jul 2021909140
Aug 202113113161
Sep 202113313360
Oct 202112112178
Nov 202110810843
Dec 2021949443
Jan 2022818532
Feb 2022819149
Mar 2022889349
Apr 202211912842
May 2022879653
Jun 2022839149
Jul 2022667330
Aug 202211411564
Sep 2022707033
Oct 202210710934
Nov 2022899151
Dec 2022565727
Jan 2023737428
Feb 2023969932
Mar 2023707130
Apr 2023515129
May 2023474716
Jun 2023626223
Jul 2023757526
Aug 2023898914
Sep 2023636313
Oct 2023464615
Nov 2023384019
Dec 2023616112
Jan 2024656629
Feb 2024656518
Mar 2024757660
Total529153572183